Physician profile
Joshua Meyer
NPI 1528296118
$2,302.00
in general payments reported to CMS, 2019-2025
20 companies · $586 in 2025
The $586 reported for 2025 was less than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $443 · 2020: $43.18 · 2021: $432 · 2022: $119 · 2023: $211 · 2024: $469 · 2025: $586.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,266.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,265.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $735.43 | 2019-2024 | Senza |
| Globus Medical, INC. | $484.39 | 2025 | Senza, Omnia |
| Boston Scientific Corporation | $363.39 | 2019-2025 | Superion Indirect Decompression System, Intracept, Wavewriter Alpha Prime 16 |
| Abbott Laboratories | $222.26 | 2019-2025 | Proclaim |
| Collegium Pharmaceutical, INC. | $128.24 | 2019-2024 | Xtampza |
| Spr Therapeutics, INC | $47.96 | 2024 | Sprint Pns System |
| Biodelivery Sciences International, INC. | $45.05 | 2019-2021 | |
| Fidia Pharma USA INC. | $41.61 | 2019-2020 | |
| Bioventus LLC | $32.15 | 2023 | Gelsyn-3 |
| Pfizer INC. | $22.40 | 2019 | |
| Saluda Medical Americas, INC. | $21.99 | 2025 | Evoke |
| Assertio Therapeutics, INC. | $21.39 | 2019 | |
| Medtronic USA, INC. | $20.82 | 2019 | |
| Stryker Corporation | $19.25 | 2019 | |
| Scilex Pharmaceuticals INC. | $18.99 | 2023 | Ztlido |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spinal Simplicity, LLC | $17.60 | 2025 | Ha Minuteman G3-R |
| Takeda Pharmaceuticals U.S.A., INC. | $17.18 | 2019 | |
| Trevena, INC. | $17.07 | 2024 | Olinvyk |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.21 | 2019 | |
| Mdd US Operations, LLC | $11.62 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joshua Meyer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.